The global breast cancer drug market is anticipated to be valued at USD 10,733.1 million in 2023, with expectations to expand to approximately USD 12,012.1 million by 2033. This growth represents a compound annual growth rate (CAGR) of 1.1% over the forecast period from 2023 to 2033. The market expansion is primarily fueled by the increasing prevalence of breast cancer and the continuous …